[{"address1": "710 Medtronic Parkway", "city": "Minneapolis", "state": "MN", "zip": "55432-5604", "country": "United States", "phone": "763 514 4000", "website": "https://www.medtronic.com", "industry": "Medical Devices", "sector": "Healthcare", "longBusinessSummary": "Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Minneapolis, Minnesota.", "fullTimeEmployees": 95000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Geoffrey Straub Martha", "age": 53, "title": "Chairman of the Board & CEO", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 3560768, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sean M. Salmon", "age": 58, "title": "Executive VP & President of Cardiovascular Portfolio", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 1681636, "exercisedValue": 493082, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brett A. Wall", "age": 57, "title": "Executive VP & President of Neuroscience Portfolio", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1754240, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory L. Smith", "age": 59, "title": "Executive Vice President of Global Operations & Supply Chain", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 1757655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Gary  Corona", "title": "Senior Vice President of Global Financial Planning and Analysis & Interim CFO", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Ploof", "title": "Senior Vice President of Global Operations and Business Services", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer M. Kirk", "age": 48, "title": "Senior VP, Global Controller & Chief Accounting Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kenneth E. Washington Ph.D.", "age": 63, "title": "Senior VP and Chief Technology & Innovation Officer", "yearBorn": 1960, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laura  Mauri M.D., M.Sc.", "title": "Senior VP and Chief Scientific & Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Weispfenning", "title": "VP & Head of Investor Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 6, "compensationRisk": 3, "shareHolderRightsRisk": 6, "overallRisk": 6, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 2, "previousClose": 91.03, "open": 91.16, "dayLow": 89.095, "dayHigh": 91.18, "regularMarketPreviousClose": 91.03, "regularMarketOpen": 91.16, "regularMarketDayLow": 89.095, "regularMarketDayHigh": 91.18, "dividendRate": 2.8, "dividendYield": 0.0308, "exDividendDate": 1727395200, "payoutRatio": 0.9327, "fiveYearAvgDividendYield": 2.61, "beta": 0.854, "trailingPE": 30.097643, "forwardPE": 15.280342, "volume": 5331197, "regularMarketVolume": 5331197, "averageVolume": 6293270, "averageVolume10days": 6589820, "averageDailyVolume10Day": 6589820, "bid": 89.27, "ask": 89.24, "bidSize": 800, "askSize": 800, "marketCap": 114651611136, "fiftyTwoWeekLow": 68.84, "fiftyTwoWeekHigh": 91.49, "priceToSalesTrailing12Months": 3.5194037, "fiftyDayAverage": 81.7542, "twoHundredDayAverage": 82.7007, "trailingAnnualDividendRate": 2.77, "trailingAnnualDividendYield": 0.030429529, "currency": "USD", "enterpriseValue": 136980111360, "profitMargins": 0.12055001, "floatShares": 1280400033, "sharesOutstanding": 1282599936, "sharesShort": 14837648, "sharesShortPriorMonth": 13680567, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0116, "heldPercentInsiders": 0.0025799999, "heldPercentInstitutions": 0.85893, "shortRatio": 2.48, "shortPercentOfFloat": 0.0116, "bookValue": 37.386, "priceToBook": 2.391002, "lastFiscalYearEnd": 1714089600, "nextFiscalYearEnd": 1745625600, "mostRecentQuarter": 1721952000, "earningsQuarterlyGrowth": 0.317, "netIncomeToCommon": 3927000064, "trailingEps": 2.97, "forwardEps": 5.85, "pegRatio": 2.96, "lastSplitFactor": "2:1", "lastSplitDate": 938390400, "enterpriseToRevenue": 4.205, "enterpriseToEbitda": 15.054, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "MDT", "underlyingSymbol": "MDT", "shortName": "Medtronic plc.", "longName": "Medtronic plc", "firstTradeDateEpochUtc": 105197400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c9b9ae1b-4267-324d-8899-95d8371bbb3b", "gmtOffSetMilliseconds": -14400000, "currentPrice": 89.39, "targetHighPrice": 106.0, "targetLowPrice": 82.0, "targetMeanPrice": 93.87, "targetMedianPrice": 95.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 27, "totalCash": 7842999808, "totalCashPerShare": 6.115, "ebitda": 9098999808, "totalDebt": 27864999936, "quickRatio": 1.347, "currentRatio": 2.133, "totalRevenue": 32576999424, "debtToEquity": 57.859, "revenuePerShare": 24.709, "returnOnAssets": 0.04474, "returnOnEquity": 0.07948, "freeCashflow": 4958499840, "operatingCashflow": 6897999872, "earningsGrowth": 0.356, "revenueGrowth": 0.028, "grossMargins": 0.65525, "ebitdaMargins": 0.27931, "operatingMargins": 0.17511, "financialCurrency": "USD", "trailingPegRatio": 1.6861, "__fetch_time": "2024-09-05"}]